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Summary    The desaturation of [1-14C]18:3n-3 to docosahexaenoic acid (DHA; 22:6n-3) is 
enhanced in an essential fatty acid deficient cell line (EPC-EFAD) in comparison with the parent 
cell line (EPC) from carp.  In the present study, the effects of DHA on lipid and fatty acid 
compositions, and the metabolism of [1-14C]18:3n-3 were investigated in EPC-EFAD cells in 
comparison with EPC cells. DHA supplementation had only relatively minor effects on lipid 
content and lipid class compositions in both EPC and EPC-EFAD cells, but significantly 
increased the amount of DHA, 22:5n-3, eicosapentaenoic acid (EPA; 20:5n-3), total n-3 
polyunsaturated fatty acids (PUFA), total PUFA and saturated fatty acids in total lipid and total 
polar lipid in both cell lines.  Retroconversion of supplemental DHA to EPA was significantly 
greater in EPC cells.  Monounsaturated fatty acids, n-9 and n-6PUFA were all increased in total 
lipid and total polar lipid in both cell lines by DHA supplementation.  The incorporation of [1-
14C]18:3n-3 was greater into EPC-EFAD compared to EPC cells but DHA had no effect on the 
incorporation of [1-14C]18:3n-3 in either cell line.  In contrast, the conversion of [1-14C]18:3n-3 
to tetraenes, pentaenes and total desaturation products was similar in the two cell lines and was 
significantly reduced by DHA supplementation in both cell lines.  However, the production of 
DHA from [1-14C]18:3n-3 was significantly greater in EPC-EFAD cells compared to EPC cells 
and, whereas DHA supplementation had no effect on the production of DHA from [1-14C]18:3n-
3 in EPC cells, DHA supplementation significantly reduced the production of DHA from [1-
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14C]18:3n-3 in EPC-EFAD cells.  Greater production of DHA in EPC-EFAD cells could be a 
direct result of significantly lower levels of end-product DHA in these cells’ lipids compared to 
EPC cells.   Consistent with this, the suppression of DHA production upon DHA 
supplementation was associated with increased cellular and membrane DHA concentrations in 
EPC-EFAD cells.  However, an increase in cellular DHA content to similar levels failed to 
suppress DHA production in DHA-supplemented EPC cells.  A possible explanation is that 
greatly increased levels of EPA, derived from retroconversion of the added DHA, acts to offset 
the suppression of the pathway by DHA by stimulating conversion of EPA to DHA in DHA-
supplemented EPC cells. 
 
INTRODUCTION 
The essential fatty acid (EFA) requirement for common carp (Cyprinus carpio) can be met by 
1.0%  of the C18 polyunsaturated fatty acids (PUFA), α-linolenate (18:3n-3) and/or linoleate 
(18:2n-6).1  A cell line from carp, EPC (epithelial papilloma)2 was shown to be able to convert 
the C18 PUFA to long-chain highly unsaturated fatty acids (HUFA) such as arachidonic (20:4n-
6), eicosapentaenoic (EPA; 20:5n-3) and docosahexaenoic (DHA; 22:6n-3) acids.3  We 
developed a cell line, EPC-EFAD, derived from EPC cells, that can survive and proliferate in an 
essential fatty acid-deficient (EFAD) medium based on delipidated serum despite containing 
virtually no n-3 and n-6HUFA.4,5   We have used these cell lines to investigate HUFA production 
and the pathways of fatty acid desaturation and elongation.  Both cell lines desaturated the n-3 
fatty acids, [1-14C]18:3n-3 and [1-14C]20:5n-3, to a greater extent than the n-6 fatty acids, [1-
14C]18:2n-6 and [1-14C]20:4n-6.3  However, the desaturation of all the radiolabelled PUFA was 
significantly greater in EPC-EFAD cells compared to EPC cells.3  The metabolism of [1-
14C]18:3n-3 was primarily increased in EPC-EFAD cells at the level of Δ5 desaturase and 
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subsequent steps in the pathway with DHA production being 4.4-fold greater in the EFAD cells.3   
In a recent study, the effects of competing, unlabeled C18 PUFA, 18:2n-6, 18:3n-3, 18:3n-6 and 
18:4n-3, on the metabolism of [1-14C]18:3n-3 were investigated.6  The incorporation of [1-
14C]18:3n-3 in both EPC and EPC-EFAD cell lines was significantly reduced, and the 
proportions of radioactivity recovered in DHA, pentaene and tetraene products significantly 
decreased, by competing C18 PUFA.6   However, the inhibitory effect of competing C18 PUFA on 
the desaturation of [1-14C]18:3n-3 was significantly greater in EPC-EFAD cells although the 
mechanism for this was unclear.  The magnitude of the inhibitory effects of C18 PUFA on [1-
14C]18:3n-3 desaturation was dependent upon the specific fatty acid and its position in the fatty 
acid desaturation pathway with, for instance, 18:4n-3 producing a greater inhibition than 18:3n-
3.  Thus the effects of 18:4n-3 were probably a combination of product inhibition of Δ6 
desaturation of [1-14C]18:3n-3 and also by direct substrate competition for C18-20 elongase and 
subsequent steps in the pathway. 
    In summary, the previous studies had shown that the main effect of essential fatty acid 
deficiency on fatty acid desaturation in carp cells was increased production of DHA, that 
competing fatty acids showed far greater inhibition of fatty acid desaturation in EPC-EFAD 
cells, and that competing acids had differential effects based on their position in the desaturation/ 
elongation pathway.  Therefore, in the present study, rather than looking at the effects of 
competing substrate fatty acids, we have investigated the effects of DHA, as both final end 
product of the pathway and as the HUFA whose production is most influenced by EFA 
deficiency, on the metabolism of [1-14C]18:3n-3 in EPC and EPC-EFAD cells.  Specifically, both 
cell lines were grown in the presence or absence of DHA after which the cultures were washed 
and the activities of the fatty acid desaturation/ elongation pathway were determined by 
incubation with [1-14C]18:3n-3.   The effects on fatty acid incorporation and desaturation were 
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determined and related to the effects of DHA supplementation on cellular lipid and fatty acid 
compositions.   
 
MATERIALS AND METHODS 
 
Cells and media 
The carp (Cyprinus carpio) epithelioma papillosum (EPC) cell line, which retains epithelial 
morphology, was routinely maintained in Leibovitz L-15 medium and supplemented with 2 mM 
glutamine, antibiotics (50 I.U. ml-1 penicillin and 50 mg.ml-1 streptomycin) and 10% fetal bovine 
serum (FBS).2  EPC-EFAD cells were derived from EPC cells by subculture in Leibovitz L-15 
medium with exactly the same supplements except that the FBS was delipidated prior to use, 
essentially as described by Capriotti and Laposata.7  Delipidated serum had been used previously 
to develop cultured mammalian cell lines that can grow in the absence of EFA.8-10   The 
delipidated FBS contained approximately 10 µg of fatty acids per g of serum (0.001% by weight) 
with less than 2 µg/g of C18 PUFA, predominantly 18:2(n-6).4,5   The EPC-EFAD cells used in the 
experiments had been maintained continuously in delipidated medium for over 5 years and were 
at passage number 100.  
 
Incubation conditions 
The EPC and EPC-EFAD cells were cultured at 22 oC in sealed plastic tissue culture flasks.   
EPC cells were cultured in standard tissue culture flasks (Iwaki Flasks, Asahi Techno Glass, 
Chiba, Japan), whereas the EPC-EFAD line was cultured in surface-modified “Primaria” flasks 
(Falcon, Becton Dickinson UK Ltd., Oxford).   Both EPC and EPC-EFAD lines were cultured in 
75 cm2 flasks and were subcultured within 24 h of reaching confluence at seeding densities of 1 
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x, and 2 x 105 cells.cm-2, respectively, to account for the slower proliferation rate of the EPC-
EFAD cells in delipidated FBS.4,5   For each experimental sample, 3 x 75 cm2 flasks were seeded 
and this experiment was repeated three times to obtain the replicates. 
 
Supplementation of cultures with 22:6n-3 and incubation with  [1- 14C]18:3n-3 
The medium was aspirated, the cultures washed with Dulbecco’s phosphate-buffered saline 
(PBS) and fresh Leibovitz L-15 medium, as above and including 10% serum or delipidated 
serum, was added. For each cell line, half the flasks received 22:6n-3, added at a final 
concentration of 20  µM, bound to fatty acid-free bovine serum albumin (BSA) in PBS.11  The 
remaining flasks of each cell line cultured without supplementary DHA received an equal 
volume of fatty acid-free BSA-PBS solution.  Flasks were incubated at 22 oC for 3 days before a 
second dose of 20 µM unlabeled 22:6n-3 was applied to the cells and incubation continued for a 
further 3 days at 22 oC.   After this preincubation period with 22:6n-3, the medium was again 
aspirated, the cultures washed twice, first with Hank’s balanced salt solution without calcium 
and magnesium (HBSS) containing 1% fatty acid-free BSA and then with PBS, and fresh 
Leibovitz L-15 medium, as above but without serum, was added.  The [1-14C]18:3n-3 (0.25 µCi 
per flask; concentration, 1.0 µM) was added to all flasks as fatty acid-free BSA-PBS complexes 
prepared as described previously12 and incubation continued for 4 days at 22 oC.   
 
Lipid extraction and incorporation of radioactivity into total lipid 
The medium was aspirated and cultures washed twice with 20 ml of ice-cold HBSS.  Cells were 
harvested by trypsinization with 0.05 % trypsin/0.5 mM ethylenediamine tetraacetic acid 
(EDTA), washed first with 5 ml ice-cold HBSS containing 1% fatty acid-free BSA and then with 
5 ml HBSS. An aliquot of 50 µl of the cells was taken and protein determined according to the 
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method of Lowry et al13 after incubation with 0.2 ml of 0.25% (w/v) sodium dodecyl sulfate/1M 
NaOH for 45 min at 60oC. Total lipid was extracted from the cell pellets with 5 ml ice-cold 
chloroform/methanol (2:1, v/v) containing 0.01% butylated hydroxytoluene (BHT) as 
antioxidant, essentially according to Folch et  al14 as described in detail previously.15  Lipid 
content was determined gravimetrically after 1 h vacuum desiccation and the lipid resuspended 
in chloroform/methanol (2:1, v/v) containing BHT, at a lipid concentration of 10 mg.ml-1, and 
samples stored at  -20 oC before analyses.   The radioactive content of total lipid was determined 
in 3 aliquots of 5 µl in mini-vials containing 2.5 ml scintillation fluid (Ecoscint A; National 
Diagnostics, Atlanta, U.S.A.) using a TRI-CARB 2000CA liquid scintillation spectrophotometer 
(United Technologies Packard).  Results were corrected for counting efficiency and quenching 
using an appropriate calibration curve.   All solvents contained 0.01% BHT as antioxidant. 
 
Separation of total polar lipids and fatty acid analysis 
Samples of total lipid (300 µg) were applied as 3 cm streaks to thin-layer chromatography (TLC) 
plates, and polar lipids separated from neutral lipids using hexane/diethyl ether/acetic acid 
(90:10:1, by vol.) as developing solvent.  The origin area corresponding to total polar lipids was 
scraped into stoppered conical glass test tubes for transmethylation directly on the silica.16  Fatty 
acid methyl esters (FAME) of total cell lipid or total polar lipids, purified as above, were 
prepared by acid-catalyzed transmethylation, and extracted and purified by high-performance 
TLC (HPTLC) as described previously.17  Analysis of FAME was performed by capillary gas 
chromatography in a Fisons GC8000 gas chromatograph (Crawley, UK) equipped with a fused-
silica capillary column (30m x 0.32 mm i.d., CP Wax 52 CB, Chrompack, UK) using hydrogen 
as carrier gas. Temperature programming was from 50 to 150°C at 35°C/min and to 225°C at 
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2.5°C/min. Individual FAME were identified by comparison with known standards and 
published data.18,19 
 
Incorporation of radioactivity into polyunsaturated fatty acids 
TLC plates were impregnated  by spraying with 2 g silver nitrate in 20 ml acetonitrile and 
activated at 110 oC for 30 min. Total lipid FAME were applied as 2.5 cm streaks and plates 
developed with toluene/acetonitrile (95:5, v/v) to separate PUFA.20   Autoradiography was 
performed using Kodak MR2 film for 6 days at room temperature. Silica corresponding to 
different FAME was scraped into scintillation vials containing 2.5 ml scintillation fluid and 
radioactivity determined as described above. 
 
Materials 
[1-14C]18:3n-3 (50 mCi.mmol-1 and 99% pure) was obtained from NEN Life Science Products 
(Hounslow, U.K.).   Unlabeled 22:6n-3 (approx. 98% pure), Leibovitz L-15 medium, HBSS, 
PBS, glutamine, penicillin, streptomycin, FBS,  trypsin/EDTA , fatty acid-free BSA and BHT 
were obtained from Sigma Chemical Co. Ltd. (Poole, UK). TLC plates (20 cm x 20 cm x 0.25 
mm) and HPTLC plates (10 cm x 10 cm x 0.15 mm), pre-coated with silica gel 60 were obtained 
from Merck (Darmstadt, Germany).  All solvents were of HPLC grade and were obtained from 
Rathburn Chemicals (Walkerburn, Peebleshire,  Scotland).     
 
Statistical analysis 
All results are means + SD of three experiments. Where indicated, data were subjected to two-
way and/or one-way analysis of variance (ANOVA) to determine the significance of effects due 
to cell line and fatty acid supplement, and where appropriate the significance of differences were 
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determined by Tukey’s post-test.  Percentage data were subjected to arc-sin transformation prior 
to further statistical analysis. Differences are reported as significant when p < 0.05.21 
 
RESULTS  
The lipid contents and class compositions of the EPC and EPC-EFAD cell lines are shown in 
Table 1.  The data were subjected to two-way analysis of variance (ANOVA) to determine the 
significance of effects due to EFA deficiency and DHA supplementation (Table 2).  The lipid 
content of the cells relative to protein content was not significantly affected by EFA deficiency 
and DHA supplementation also had no significant effect in either cell line.  EPC-EFAD cells 
were characterised by significantly decreased proportions of cholesterol and phosphatidylcholine 
(PC), and significantly increased proportions of phosphatidylethanolamine (PE), 
phosphatidylinositol (PI) and total polar lipids (Tables 1 and 2).  Supplementation with DHA 
significantly increased the proportions of total polar lipids in both cell lines.   However, whereas 
DHA supplementation decreased the proportions of cholesterol and PE and increased the 
proportion of PC in EPC cells, it had little effect on the relative proportions of these three major 
lipid classes in EPC-EFAD cells (Table 1). 
     There was no significant difference in total fatty acid content of the two cell lines when the 
results were expressed relative to protein content and although DHA supplementation tended to 
increase the total fatty acid content in both cell lines, these effects were non significant (Table 3).  
Expressing the total lipid fatty acid composition of the cell lines relative to cell protein content 
showed that EPC-EFAD cells contained very reduced amounts of n-6 and n-3 PUFA which was 
compensated entirely by increased amounts of n-9 PUFA so that total PUFA content was 
identical in the two cell lines.  The levels of saturated fatty acids in total lipid were slightly lower 
in EPC-EFAD cells mainly due to reduced 16:0 and 18:0 whereas the levels of total 
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monounsaturated fatty acids were identical in the two cell lines despite EPC-EFAD cells 
showing a lower level of 18:1n-9.  DHA supplementation increased the levels of DHA, 22:5n-3, 
EPA, total n-3PUFA, total PUFA and total saturated fatty acids in total lipid in both cell lines 
and decreased the amounts of n-9 PUFA and monoenes, particularly 18:1n-9 (Table 3).  These 
effects of DHA supplementation tended to be quantitatively greater in EPC cells but, in 
particular, the level of EPA was increased in EPC cells to a level over 3-fold greater than in 
EPC-EFAD cells.  
      Similar patterns were observed in the fatty acid compositions of polar lipids (Table 4). EPC-
EFAD cells showed reduced proportions of n-6 and n-3 PUFA, compensated by increased n-9 
PUFA, along with a lower proportion of saturated fatty acids and similar a level of total 
monounsaturated fatty acids despite EPC-EFAD cells showing a lower proportion of 18:1n-9 
compared to EPC cells.  As with total lipid, DHA supplementation decreased the proportions of 
n-9 PUFA and monoenes, particularly 18:1n-9, in polar lipid in both cell lines and increased the 
proportions of saturated fatty acids, DHA, 22:5n-3, EPA, total n-3PUFA and total PUFA with 
the percentage of EPA increased in EPC cells to a level over 3-fold greater than in EPC-EFAD 
cells (Table 4). 
       The incorporation of [1-14C]18:3n-3 was significantly greater in EPC-EFAD cells compared 
to EPC cells and DHA supplemenation had no significant effect on this (Fig.1).  In contrast, the 
conversion of [1-14C]18:3n-3 to all desaturation products (sum total of radioactivity recovered as 
desaturated products including 18:4n-3, 20:4n-3, 22:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3) was not 
significantly different between EPC and EPC-EFAD cells but DHA supplementation 
significantly reduced the destauration of [1-14C]18:3n-3 in both cell lines (Fig.2, top panel).  This 
was mainly a reflection of the effects on the production of tetraene products, which accounted for 
approximately 45% (EPC + DHA) to 64% (EPC-EFAD + DHA) of the total desaturated products 
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(Fig.2, middle panel).  Pentaenes products accounted for between 33% (EPC-EFAD + DHA) and 
50% (EPC + DHA) of the total desturated products and also showed no significant  difference 
between cell line but were significantly reduced in DHA supplemented cells (Fig. 2, bottom 
panel).  However, the reduction in radioactivity recovered in pentaene products was significantly 
greater in EPC-EFAD cells.  Two-way ANOVA confirmed that incorporation of [1-14C]18:3n-3 
was only affected by cell line and not DHA supplementation, whereas desaturation of [1-
14C]18:3n-3 to all desaturated products and tetraenes was only significantly affected by DHA 
supplementation and not by cell line whereas production of pentaene products was also 
significantly affected by cell line (Table 5).  However, the production of DHA from [1-
14C]18:3n-3 was significantly affected by both factors. DHA production from [1-14C]18:3n-3 was 
significantly greater in EPC-EFAD cells compared to EPC cells and DHA supplementation 
considerably reduced this conversion in EPC-EFAD cells whereas DHA supplementation had 
little effect on conversion of [1-14C]18:3n-3 to DHA in EPC cells (Fig. 3).  Two-way ANOVA 
showed the very significant interaction between effects due to cell line and DHA 
supplementation on DHA production from [1-14C]18:3n-3, i.e. the effects of DHA 
supplementation were highly dependent upon cell line and as the difference between EPC and 
EPC-EFAD cell lines was completely reversed by supplementation with DHA (Table 5). In 
contrast, the effects due to cell line and DHA supplementation were entirely independent for 
incorporation and conversion of [1-14C]18:3n-3 to other desaturation products (Table 5). 
 
DISCUSSION 
The primary aim of the present study was to determine the effects of DHA, as the end product of 
the PUFA biosynthetic pathway, on PUFA desaturation/elongation in a cell culture model of 
EFA deficiency, the EPC-EFAD cell line, in comparison with the non-deficient line, EPC.  In 
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addition, the study aimed to relate the effects on the PUFA biosynthetic pathway in the cell lines 
with changes in the fatty acid composition of the cellular lipids. The results of the study have 
shown that, while the effects of DHA supplementation were similar in both cell lines in some 
instances, DHA supplementation could have differential effects depending upon the EFA status 
of the cells.  Thus, incorporation of [1-14C]18:3n-3 was increased by EFA deficiency but DHA 
supplementation did not affect these processes. Conversely, the capacity to desaturate [1-
14C]18:3n-3 to tetraene and pentaene products was not affected by EFA deficiency but was 
suppressed by DHA supplementation in both cell lines.  Significant effects of EFA deficiency on 
PUFA desaturation were observed mainly on DHA production, with this being increased by EFA 
deficiency. However, DHA supplementation only significantly inhibited DHA production in 
EPC-EFAD cells and similarly, the suppression of pentaene production by DHA 
supplementation was greater in EPC-EFAD cells compared to EPC cells. 
      Net “incorporation” is based on the recovery of radioactivity in the cells and will be 
dependent on the initial uptake of fatty acid less the amount of fatty acid oxidized or lost through 
other metabolic pathways.  We had shown previously that incorporation of PUFA is increased in 
the cell culture model of EFA deficiency, EPC-EFAD cells, compared to their non-deficient 
parent cells, EPC.3,6   In a recent dietary trial, the incorporation of 18:2n-6 and 18:3n-3 was 
increased in hepatocytes from Atlantic salmon (Salmo salar) fed an EFA deficient diet compared 
to one fed an n-3-supplemented diet.22   The present study has confirmed this result but also 
showed that prior supplementation of the cells with DHA did not affect the PUFA uptake and 
incorporation processes in either cell line.    The present study was performed under conditions 
where neither cell line was metabolically predisposed to storing lipid.23   This is perhaps obvious 
with EPC-EFAD cells, being cultured in delipidated FBS, but even culture in 10% FBS does not 
lead to the deposition of lipid in the form of lipid droplets in the EPC cell line and so levels of 
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neutral lipid in both cell lines are low.3  Similarly, we have shown previously that 
supplementation with PUFA at 20 µM is able to significantly alter fatty acid compositions of 
phospholipids without significantly increasing neutral lipid in these cells.5   Therefore, the DHA 
supplementation used in the present study was sufficient to dramatically increase DHA levels in 
polar lipids in both cell lines without inducing any increase in neutral lipid stores.  In 
consequence, the results show that an increase in membrane DHA alone did not affect apparent 
processes of uptake and incorporation of [1-14C]18:3n-3.  Previously, we found that competing 
PUFA, added along with [1-14C]18:3n-3, inhibited the apparent uptake of [1-14C]18:3n-3, as 
would be expected, but interestingly the inhibition was significantly less in EPC-EFAD cells 
compared to EPC cells.6 
          The EPC-EFAD cells have now been cultured continuously in delipidated FBS for over 5 
years and 100 passages.  Lipid content per cell is lower in the EPC-EFAD cells compared to EPC 
cells3 but the present study showed that the lipid content relative to cell protein is similar in the 
two cell lines and EFA deficiency had only relatively minor effects on phospholipid class 
composition.  Therefore, the main effects of EFA deficiency were on fatty acid compositions 
which were characterised in EPC-EFAD cells by increased n-9PUFA, particularly 20:2n-9 and 
20:3n-9, balancing the very reduced levels of n-3 and n-6PUFA.  The reduced amount of 18:1n-
9, possibly related to increased metabolism to n-9PUFA, was compensated by increased levels of 
the other monoenoic fatty acids.  These differences between EPC and EPC-EFAD cells are 
presumably adaptations to maintain the fluidity of the cellular membranes and, consistent with 
this, reduced cholesterol in the EPC-EFAD cells, as observed in the present study,  has also been 
a consistent feature of EFA deficiency in this cell culture model.3,4   Other studies on mammalian 
cell culture models of EFA deficiency have reported broadly similar changes in fatty acid 
composition but have not reported lipid class compositions and so the effects of EFA deficiency 
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on cholesterol levels in these cells is not known.8-10,24,25  
       The present study clearly demonstrated that there was no difference between EPC and EPC-
EFAD cells in the amount of [1-14C]18:3n-3 desaturated to tetraene and pentaene products, i.e. 
no overall difference in the apparent activities of Δ6 and Δ5 desaturases and  C18-20 elongase.  This 
is slightly surprising as mammalian dietary studies have generally suggested that Δ6 (and perhaps 
Δ5) desaturase activities are upregulated by “EFA deficiency” although the dietary modulation 
has actually been a fat-free diet rather than a diet specifically and solely devoid of PUFA.26   
However, endocrine/hormonal factors almost certainly have critical roles in regulating fatty acyl 
desaturase activities in response to nutritional status and so it is probably  not appropriate to 
directly compare cell culture studies with whole animal nutritional trials.27,28   Few data are 
available on fatty acyl desaturase activities in cell culture models of EFA deficiency but it has 
been reported that both Δ6 and Δ5 desaturase activities were upregulated in human HepG2 cells 
in EFA deficient conditions although this was a short term, acute deficiency (2 weeks) compared 
to the long-term adapted EPC-EFAD line.29    In an earlier study with EPC-EFAD cells, 
expressing the results as percentage of substrate desaturated rather than the absolute terms used 
in the present study, we noted that there was increased desaturation of both [1-14C]18:3n-3 and 
[1-14C]18:2n-6 in EPC-EFAD cells compared to EPC cells.3  In that study however, the greatest 
increase in [1-14C]18:3n-3 desaturation in EPC-EFAD cells was in DHA production, which was 
increased 4.4-fold, with pentenes increased only 1.5-fold and tetraene production actually being 
1.4-fold lower in EPC-EFAD cells than in EPC cells.3  This is similar to the results in the present 
study where only DHA production was greater (by 2-fold) in EPC-EFAD cells compared to EPC 
cells.  
         DHA supplementation increased the level of DHA and total n-3PUFA, of course, and also 
decreased n-9PUFA as expected, in both cell lines.  The absolute amount of PUFA and their 
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relative proportion in total fatty acids was also increased in both cells lines in respose to DHA 
supplementation, with general membrane fluidity requirements being compensating by increased 
saturated fatty acids and decreased monoenes, particularly 18:1n-9 which was reduced to similar 
levels in EPC and EPC-EFAD cells.  The effects of DHA supplementation on fatty acid 
compositions in EPC-EFAD cells were similar to those observed in a previous study which had 
shown that, like the present study, supplemental DHA was, in part, retroconverted to EPA in 
EPC-EFAD cells.5  However, EPC cells were not investigated in the previous study.  The present 
study has shown that the process of retroconversion was considerably greater in EPC cells such 
that EPA levels were some 3-fold higher in DHA-supplemented EPC cells than in DHA-
supplemented EPC-EFAD cells.  DHA levels before DHA supplementation are almost 10-fold 
higher in EPC cells compared to EPC-EFAD cells and so it appears that this level of DHA, 
although not high in absolute terms, may result in more of the supplemental DHA being 
retroconverted.  In effect, retroconversion of DHA, which requires saturation of the Δ4 double 
bond by 2,4-enoyl-CoA reductase and peroxisomal chain shortening via limited β-oxidation, 
appears to be inhibited by EFA deficiency.  Retroconversion of DHA to 22:5n-3 and EPA has 
been observed previously in various animal tissues30-32 and retroconversion of DHA to 22:5n-3 
and EPA, and 22:5n-3 to EPA has been reported in various cells in culture.22,33-35   In contrast, in 
rat  UIII (uterine stromal) cells, which show higher levels of DHA production from 18:3n-3 than 
most other cell lines, there was no significant retroconversion of DHA, added at 5 µM.36   To our 
knowledge the effects of EFA deficiency on retroconversion processes in cell cultures has not 
been reported previously, but retroconversion of DHA to EPA and 22:5n-3 was reported to be 
increased in hepatocytes prepared from salmon fed an EFA deficient diet in comparison with 
hepatocytes from salmon fed an n-3PUFA supplemented diet.22 
         Prior supplementation with DHA also very significantly reduced the 
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desaturation/elongation of [1-14C]18:3n-3 to tetraene and pentaene products in both cell lines.  
This could be interpreted as being consistent with end-product inhibition as a result of greatly 
increased membrane DHA levels.  Certainly, inhibition or repression of Δ6 and Δ5 desaturase 
activities in response to feeding fish oils, rich in DHA (and EPA) is a consistent observation of 
dietary trials in mammals.26,37    An unexpected result in the present study was the greater effect 
of DHA in inhibiting DHA and, to a lesser extent, pentaene production in EPC-EFAD cells 
compared to EPC cells.  A possible explanation could be that the level of DHA in EPC cell polar 
lipids is sufficient to exert a suppressive effect on DHA synthesis that is not increased by a 
further increase in DHA level but which is reduced by EFA deficiency.  This would imply that 
the presence or absence of end product DHA can only affect DHA production in these cells by 
an order of 2-fold.  An alternative explanation could be that the apparent inability of DHA to 
inhibit DHA production in EPC cells was related to the level  of EPA, produced through 
retroconversion of the added DHA. Increased EPA may stimulate the conversion of EPA to 
DHA and thus counteract the suppressive effect of DHA.  
         In conclusion, the present study determined the effects of DHA, as the end product of the 
PUFA biosynthetic pathway, on PUFA desaturation/elongation in a cell culture model of EFA 
deficiency, and attempted to relate the effects on the PUFA biosynthetic pathway with changes 
in the fatty acid composition of the cellular lipids.  The results showed that the effects of DHA 
supplementation were generally similar in both EPC and EPC-EFAD cells.  However,  whereas 
DHA supplementation inhibited biosynthesis of DHA from [1-14C]18:3n-3 in EPC-EFAD cells, 
it had no effect on DHA synthesis in EPC cells.  This may be related to the differing levels of 
DHA and/or EPA between EPC and EPC-EFAD cells both prior and subsequent to DHA 
supplementation. 
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Legends to Figures 
 
Fig.1. Effects of supplementation with 22:6n-3 on the incorporation of [1-14C]18:3n-3 into EPC 
and EPC-EFAD cells.  Results are presented as means ± S.D. of triplicate experiments. Mean 
values with different letters are significantly different (P < 0.05) as determined by one-way 
analysis of variation (ANOVA) followed by Tukey’s post-test.  , unsupplemented and   , 
supplemented with 20 µM 22:6n-3 as described in the Materials and Methods section. 
 
 Fig.2. Effects of supplementation with 22:6n-3 on the desaturation of [1-14C]18:3n-3 in EPC and 
EPC-EFAD cells.  Panels represent the amount of [1-14C]18:3n-3 converted to all desaturated 
products (sum total of radioactivity recovered as 18:4n-3, 20:4n-3, 22:4n-3, 20:5n-3, 22:5n-3 and 
22:6n-3) (top panel), tetraene products (total radioactivity recovered as 18:4n-3, 20:4n-3 and 
22:4n-3) (middle panel) and pentaene products (total radioactivity recovered as 20:5n-3 and 
22:5n-3) (bottom panel).  Results are presented as means ± S.D. of triplicate experiments. Mean 
values with different letters are significantly different (P < 0.05) as determined by one-way 
analysis of variation (ANOVA) followed by Tukey’s post-test.  , unsupplemented and   , 
supplemented with 20 µM 22:6n-3 as described in the Materials and Methods section. 
 
Fig.3. Effects of supplementation with 22:6n-3 on the production of 22:6n-3 from [1-14C]18:3n-3 
in EPC and EPC-EFAD cells.  Results represent the amount of [1-14C]18:3n-3 converted to 
22:6n-3 and are presented as means ± S.D. of triplicate experiments. Mean values with different 
letters are significantly different (P < 0.05) as determined by one-way analysis of variation 
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(ANOVA) followed by Tukey’s post-test.  , unsupplemented and   , supplemented with 20 
µM 22:6n-3 as described in the Materials and Methods section.  
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